ISS (Integrated Surgical Systems) makes ROBODOC sale to India:
This article was originally published in Clinica
Integrated Surgical Systems (ISS) has sold a ROBODOC surgical assistant system to the government of India. "India is a fast-growing industrial nation with a population that demands and supports advanced medical care," said Ramesh Trivedi, CEO of Davis, California-based ISS. "India therefore represents a substantial business opportunity for ISS." Rajesh Bhatia, managing director of ISS' Indian distributor Paramount Impex, said: "We see significant opportunity for the ROBODOC system throughout India and its neighbouring countries."
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.